Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activities

Ping Yang1, Yawen Zhang, Junfeng Pang

  • 1Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

Janus kinase 2 (Jak2) is crucial for adult blood vessel function. Loss of Jak2 impairs blood vessel relaxation, growth, and repair after injury, impacting endothelial homeostasis and recovery.

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Physiology

Background:

  • The precise role of Janus kinase 2 (Jak2) in maintaining adult endothelial homeostasis remains unclear due to conflicting results from inhibitor studies.
  • Jak2 deficiency causes embryonic lethality, necessitating models to study its postnatal functions in endothelial cells.

Purpose of the Study:

  • To elucidate the specific role of Jak2 in regulating postnatal endothelial function and homeostasis.
  • To investigate the impact of Jak2 deficiency on vascular responses, angiogenesis, and ischemic injury recovery.

Main Methods:

  • Generation of a tamoxifen-inducible Jak2-deficient adult mouse model.
  • Assessment of endothelium-dependent vasodilation, in vivo angiogenesis using Matrigel plug assays, and hindlimb ischemia models.
  • Analysis of perfusion recovery, neovascularization, and expression of key proteins like eNOS via antibody arrays and signaling pathway analysis.

Main Results:

  • Jak2 deficiency significantly impaired endothelium-dependent vasodilation and reduced angiogenic capacity.
  • Loss of Jak2 delayed perfusion recovery in a hindlimb ischemia model, with decreased capillary and arteriole formation.
  • Jak2 deficiency repressed eNOS expression by attenuating the Raf-1/MEK1/Sp-1 signaling pathway.

Conclusions:

  • Jak2 is essential for normal postnatal endothelial function, including vasodilation, angiogenesis, and ischemic repair.
  • The Jak2-eNOS pathway, involving Raf-1/MEK1/Sp-1 signaling, is critical for endothelial homeostasis and vascular recovery.
  • Targeting Jak2 may offer therapeutic potential for conditions involving vascular dysfunction.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...